Therapeutics Metabolic and Endocrine Agents

Clonidine in the treatment of premenstrual syndrome: a subgroup study

Giannini AJ, Sullivan B, Sarachene J, Loiselle RH

Published February 1988 The Journal of Clinical Psychiatry, 49(2), 62-63
PMID 2962993

Abstract

The authors studied the effects of clonidine on a subgroup of women who had symptoms associated with premenstrual syndrome; the subgroup comprised 24 women aged 19 to 41 years who had "moderate" to "severe" cyclic decreases in beta-endorphin levels. All of the women received clonidine and placebo in a double-blind cross-over design that spanned four menstrual cycles. Clonidine was significantly (p less than .05) more effective than placebo in reducing symptoms.

Topics

Related research

Therapeutics › Metabolic and Endocrine Agents › Corticosteroids · Menstrual Cycle › Premenstrual Disorders › Premenstrual Syndrome Treatment · Reproductive Endocrinology › Neuroendocrinology › Opioid Peptides
PMID 2962993 2962993 Giannini et al. 1988, Giannini 1988